94 related articles for article (PubMed ID: 6205625)
1. Human leukocyte interferon administration to patients with symptomatic and suspected rabies.
Merigan TC; Baer GM; Winkler WG; Bernard KW; Gibert CG; Chany C; Veronesi R
Ann Neurol; 1984 Jul; 16(1):82-7. PubMed ID: 6205625
[TBL] [Abstract][Full Text] [Related]
2. Administration of human interferon to rabies virus-infected monkeys after exposure.
Hilfenhaus J; Weinmann E; Majer M; Barth R; Jaeger O
J Infect Dis; 1977 May; 135(5):846-9. PubMed ID: 404370
[TBL] [Abstract][Full Text] [Related]
3. [The importance of interferon for rabies prophylaxis (author's transl)].
Majer M; Weinmann E; Hilfenhaus J
MMW Munch Med Wochenschr; 1978 Mar; 120(9):285-6. PubMed ID: 417241
[TBL] [Abstract][Full Text] [Related]
4. Circulating interferon in man after administration of exogenous human leukocyte interferon.
Emödi G; Just M; Hernandez R; Hirt HR
J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
Baysal B; Tosun S; Ozdemir M; Doğan M
Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
[TBL] [Abstract][Full Text] [Related]
6. [Local chemotherapy of cancer. Intrathecal administration].
Nagai M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):156-64. PubMed ID: 2465738
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular and/or intralumbar postexposure treatment of rabies virus-infected cynomolgus monkeys with human interferon.
Weinmann E; Majer M; Hilfenhaus J
Infect Immun; 1979 Apr; 24(1):24-31. PubMed ID: 110693
[TBL] [Abstract][Full Text] [Related]
8. Effect of administered human interferon on experimental rabies in monkeys.
Hilfenhaus J; Karges HE; Weinmann E; Barth R
Infect Immun; 1975 May; 11(5):1156-8. PubMed ID: 1168171
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Interferon administered in the cerebrospinal space and its effect on rabies in rabbits.
Ho M; Nash C; Morgan CW; Armstrong JA; Carroll RG; Postic B
Infect Immun; 1974 Feb; 9(2):286-93. PubMed ID: 4816460
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
Arnell K; Enblad P; Wester T; Sjölin J
J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
[TBL] [Abstract][Full Text] [Related]
12. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
13. Changes of antipyrine pharmacokinetics during influenza and after administration of interferon-alpha and -beta.
Brockmeyer NH; Barthel B; Mertins L; Goos M
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):309-11. PubMed ID: 9660037
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
15. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report on the clinical use of human leukocyte interferon in neuroblastoma.
Sawada T; Fujita T; Kusunoki T; Imanishi J; Kishida T
Cancer Treat Rep; 1979; 63(11-12):2111-3. PubMed ID: 393390
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours.
Fleischhack G; Reif S; Hasan C; Jaehde U; Hettmer S; Bode U
Br J Cancer; 2001 Jun; 84(11):1453-9. PubMed ID: 11384092
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B virus in children in Israel: clinical and epidemiological characteristics and response to interferon therapy.
Neudorf-Grauss R; Bujanover Y; Dinari G; Broide E; Neveh Y; Zahavi I; Reif S
Isr Med Assoc J; 2000 Feb; 2(2):164-8. PubMed ID: 10804945
[TBL] [Abstract][Full Text] [Related]
20. Equine rabies immunoglobulin: a study on its clinical safety.
Satpathy DM; Sahu T; Behera TR
J Indian Med Assoc; 2005 Apr; 103(4):238, 241-2. PubMed ID: 16173435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
